Back to Journals » Clinical Ophthalmology » Volume 13

A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease

Total article views   HTML views PDF downloads Totals
7,623 Dovepress* 6,453+ 1,916 8,369
PubMed Central* 1,170 231 1,401
Totals 7,623 2,147 9,770
*Since 12 February 2019
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar